Home » Stocks » LNSR

LENSAR, Inc. (LNSR)

Stock Price: $7.76 USD -0.31 (-3.84%)
Updated May 12, 2021 4:00 PM EDT - Market closed
Market Cap 75.33M
Revenue (ttm) 27.52M
Net Income (ttm) n/a
Shares Out 10.93M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $7.76
Previous Close $8.07
Change ($) -0.31
Change (%) -3.84%
Day's Open 8.06
Day's Range 7.50 - 8.06
Day's Volume 22,815
52-Week Range 3.16 - 12.71

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

1 week ago - Business Wire

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

2 weeks ago - Business Wire

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

2 months ago - Business Wire

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

2 months ago - Business Wire

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

3 months ago - Business Wire

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq:LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts...

3 months ago - Business Wire

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Industry
Medical Devices
Stock Exchange
NASDAQ
Ticker Symbol
LNSR
Full Company Profile

Financial Performance

In 2020, LENSAR, Inc's revenue was $26.38 million, a decrease of -13.58% compared to the previous year's $30.53 million. Losses were -$19.77 million, 34.9% more than in 2019.

Financial Statements